Kiniksa Pharmaceuticals International, plc
Develops and commercializes immune-modulating therapies for debilitating diseases with unmet needs.
KNSA | NDAQ
Overview
Corporate Details
- ISIN(s):
- BMG5269C1010
- LEI:
- Country:
- United States of America
- Address:
- 23 OLD BOND STREET, FLOOR 3, LONDON
- Website:
- https://www.kiniksa.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Kiniksa Pharmaceuticals is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for debilitating diseases with significant unmet medical needs. The company's portfolio is centered on innovative, immune-modulating assets. Its pipeline includes investigational therapies for conditions such as recurrent pericarditis, addressing diverse patient needs through novel treatments. Kiniksa operates with a patient-centric mission, aiming to deliver therapies to individuals with limited or no available treatment options.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Kiniksa Pharmaceuticals International, plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kiniksa Pharmaceuticals International, plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kiniksa Pharmaceuticals International, plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
